Cure Medicines (India) Private Limited, a active private limited company, was established on 26 March 2003 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230PN2003PTC140047. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 42 professional, Its leadership includes Ulhas Rajaram Puranik (Director), Shyam Pralhad Bothikar (Director). Past directors included Shrihari Martand Dharmadhikari, Milind Balwant Save, Rajkumar Parappa Arali. It holds ₹5.00 Cr open charges and ₹4.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Curehouse,C-12-13,Midc,Bhosari,, Pune, Maharashtra, 411026.
U24230PN2003PTC140047
140047
26 March 2003
₹5.00 M
₹3.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Cure Medicines (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ulhas Rajaram Puranik | Director | 15 Mar 2007 | Current |
| Shyam Pralhad Bothikar | Director | 15 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2014 | Past |
| Pramod Abcsdd | Director | 07 Jan 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Director | 15 Mar 2007 | Past |
| Pramod Abcsdd | Director | 29 Sep 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cure Medicines (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.32% decrease. The company also saw a substantial fall in profitability, with a 510.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cure Medicines (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹45,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹5.00 Cr | Open |
| 11 Nov 2022 | Others | ₹8.50 M | Satisfied |
| 15 Oct 2022 | Others | ₹1.50 M | Satisfied |
| 07 Jul 2017 | Others | ₹5.00 M | Satisfied |
| 18 Feb 2009 | Bank Of Maharashtra | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Cure Medicines (India) has a workforce of 42 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cure Medicines (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Medicines (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Cure Medicines (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge registered on 11 Nov 2022 via Charge ID 100646107 with Others was fully satisfied on 16 Jul 2024. was documented.
Progress on A charge registered on 15 Oct 2022 via Charge ID 100646269 with Others was fully satisfied on 16 Jul 2024. was documented.
Progress on A charge registered on 13 Aug 2003 via Charge ID 90144635 with Others was fully satisfied on 16 Jul 2024. was documented.
Progress on Cure Medicines (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity A charge with Others amounted to Rs. 50.00 M with Charge ID 100936395 was registered on 30 Mar 2024. was completed.
The CIN of Cure Medicines (India) Private Limited is U24230PN2003PTC140047.
Cure Medicines (India) Private Limited is headquartered at Curehouse,C-12-13,Midc,Bhosari,, Pune, Maharashtra, 411026.
Cure Medicines (India) Private Limited was incorporated on 26 March 2003.
The current directors of Cure Medicines (India) Private Limited are
The primary industry of Cure Medicines (India) Private Limited is Manufacturing.
Cure Medicines (India) Private Limited is unlisted.
The authorized capital of Cure Medicines (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Cure Medicines (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX